SlideShare a Scribd company logo
1 of 34
Download to read offline
Coronary Endothelial Shear Stress Profiling
In-Vivo to Predict Progression of
Atherosclerosis and In-Stent Restenosis in Man
Peter H. Stone, M.D.
Ahmet U. Coskun, Ph.D.
Scott Kinlay, M.D., Ph.D.,
Maureen E. Clark, M.S.
Milan Sonka, Ph.D.
Andreas Wahle, Ph.D.,
Olusegun J. Ilegbusi, Ph.D.
Yerem Yeghiazarians, M.D.
Jeffrey J. Popma, M.D.
Richard E. Kuntz, M.D., M.S.
Charles L. Feldman, Sc.D.
Cardiovascular Division, Brigham & Women’s Hospital, Harvard Medical School;
Department of Mechanical, Industrial and Manufacturing Engineering,
Northeastern University;
Department of Electrical and Computer Engineering, University of Iowa
Abstract - 1
The focal and eccentric nature of CAD must be
related to local hemodynamic factors. The endothelium is
uniquely capable of controlling local arterial responses by
transduction of hemodynamic shear stress. Low or
reversed shear stress (< ~10 dynes/cm2
) leads to plaque
development and progression. Physiologic shear stress
(~10 - 30 dynes/cm2
) is vasculoprotective, maintaining
normal vascular morphology. Increased shear stress
(> ~ 30 dynes/cm2
) promotes outward remodeling and
platelet aggregation.
Characterization of shear stress along the coronary
artery may allow for prediction of progression of
atherosclerosis and vascular remodeling.
Abstract - 2
Current methodologies cannot provide adequate
information concerning the micro-environment of the
coronary arteries. We developed a unique system using
intravascular ultrasound (IVUS), biplane coronary
angiography, and measurements of coronary blood flow, to
present the artery in accurate 3-D space, and to produce
detailed characteristics of intravascular flow, ESS, and
arterial wall and plaque morphology.
We observed that over 6 mo followup, areas of low
ESS demonstrated plaque progression, areas of
physiologic ESS remained quiescent, and areas of
increased ESS developed outward remodeling.
The technology may be invaluable to study the
impact of pharmacologic or device interventions on the
natural history of coronary disease.
Fundamental Nature of the Problem
• Although all portions of the coronary arterial tree
are exposed to the same systemic risk factors,
atherosclerosis is focal and eccentric
• Each coronary artery has many different
obstructions in different “stages” of evolution:
– There is not a “wave-front” of vulnerability
and consequent rupture.
Varying Degrees of CAD Lesion Severity in a
Single Coronary Artery
Fundamental Nature of the Problem
• Coronary atherosclerotic obstructions behave differently
based on the degree of luminal obstruction and morphology:
– Lesions > 50-75% obstruction Angina Pectoris
– Lesions < 50% obstruction Rupture,superimposed
thrombus,
MI, death
These small, potentially lethal lesions are,These small, potentially lethal lesions are,
therefore, “clinically silent” until they rupture.therefore, “clinically silent” until they rupture.
• It would be of enormous value to identify minorIt would be of enormous value to identify minor
obstructions which were progressing and/orobstructions which were progressing and/or
evolving towards “vulnerability” since they could beevolving towards “vulnerability” since they could be
treated before rupture occurred, thereby avertingtreated before rupture occurred, thereby averting
an acute coronary syndrome.an acute coronary syndrome.
Nature of Progression of Atherosclerosis
• The only truly local phenomena which could lead to varying
local vascular responses are endothelial shear stresses (ESS)
• Local ESS variations are critical:
– Low ESS and disturbed flow (< 6-10 dynes/cm2
)
• Causes atheroma; pro-thrombotic, pro-migration, pro-apoptosis
– Physiologic shear stress and laminar flow (10-30
dynes/cm2
)
• Vasculoprotective, anti-thrombotic, anti-migration, pro-survival
– High shear stress and turbulent flow (> 30 dynes/cm2
)
• Promotes platelet activation, thrombus formation, and probably
plaque rupture
• Until now,Until now, in vivoin vivo determination of intracoronary flow velocitydetermination of intracoronary flow velocity
and endothelial shear stress has not been possible.and endothelial shear stress has not been possible.
The Detrimental Effect of Low Shear Stress on
Endothelial Structure and Function
Low shear stresses and disturbed
local flow (< ~ 6 dynes/cm2
)
are atherogenic:
(Malek, et al. JAMA 1999; 282:2035)
• Cell proliferation, migration
• Expression of vascular adhesion
molecules, cytokines, mitogens
• Monocyte recruitment and activation
• Procoagulant and prothrombotic state
• Local oxidation
Promotes:
The Effect of Physiologic Shear Stress on
Endothelial Structure and Function
Physiologic shear stress
(~15-50 dynes/cm2
) is
vasculoprotective:
(Malek, et al. JAMA 1999; 282:2035)
• Enhances endothelial quiescence
- decreases proliferation
• Enhances vasodilation
• Enhances anti-oxidant status
• Enhances anti-coagulant and
anti-thrombotic status
Overview of Intracoronary Flow Profiling System
Patient • Coronary angiography
• Intracoronary ultrasound
• Coronary flow (TIMI Frame Count)
Acquire image data
3D reconstruction
of lumen, EEL, Plaque
Generation of grid
for Computational
Fluid Dynamics
Numerical
computation
Determination of
local velocity vectors
and shear stress
Application of
vascular data to
patient care
Prediction of
restenosis
Prediction of
CAD progression
Intracoronary Flow Profiling Methods
• The intracoronary ultrasound (ICUS) “core” is positioned in the
relevant section of the artery and a biplane angiogram is recorded
using dilute contrast.
• ICUS is performed with controlled pull-back at 0.5 mm/sec with
biplane angiography. ECG is simultaneously recorded for “gating.”
• A dynamic programming technique extracts the lumen and EEL
outline from the ICUS at end-diastolic frames and re-aligns them.
• The ICUS frames are realigned in 3-D space perpendicular to the
ICUS core image.
• The reconstructed lumen is divided into computational control
volumes comprising 0.3 mm thick slices along the segment, 40 equal
intervals around the circumference, and 16 intervals in the radial
direction.
• Dividing the blood into small “cubes” on the grid, the Navier-Stokes
equations of fluid flow are solved numerically using an iterative
procedure (Computational Fluid Dynamics).
• Shear stress at the wall is obtained by multiplying viscosity by the
velocity gradient at the wall.
Selected ICUS frames
Total number of frames ≈ 100-200/arterial segment
Measurements of Lumen, Outer Vessel Wall,
and Plaque by IVUS
(DeFranco. AJC 2001; 88 [Suppl]: 7M)
• Lumen
• Outer Vessel Wall =
Area within EEM
• Plaque = Intimal-Medial
Thickness
Stacking of ICUS frames
Top half-plane
Reconstructed Lumen
Creation of Computational Mesh
640 Cells per
cross-section
3mm
Representative Example of
3-D Reconstruction of Coronary Artery
RAO projection LAO projection
Example of 3-D Reconstruction of
Coronary Artery
Solid line passing through the centroid of the lumen defines a pathline
Perpendicular distance between pathline and lumen border defines local lumen radius,
perpendicular distance between EEL border and pathline defines the local EEL radius
Difference between local EEL and lumen radii defines local plaque thickness
Original angiogram of
a portion of an artery
studied
Composite reconstruction of portion of the arterial segment,
consisting of outer arterial wall, plaque, and lumen:
Isolated view of reconstructed outer arterial wall:
Isolated view of reconstructed lumen:
Isolated view of reconstructed atherosclerotic plaque:
Example of 3-D Reconstruction of Arterial Segment
Velocity Field Presented As A
Longitudinal Section
Coronary Endothelial Shear Stress
w
y
u
WSS
∂
∂
µ=
dynes/cm2
[Artery is displayed as if it were cut and opened longitudinally, as a
pathologist would view it.]
Reproducibility Studies of
Intra-coronary Flow Profiling Measurements
Cardiac catheterization and coronary angiography
– Patients studied completely with ICUS pullback
and biplane angiography (“Test A”)
– All catheters removed, and after a few minutes,
entire procedure repeated (“Test B”):
• catheters reinserted
• angle, skew, table height reproduced to mimic
the initial procedure
– All calculations performed to measure lumen,
outer vessel, plaque morphology, and endothelial
shear stress
Reproducibility of 3-D Coronary Artery
Reconstruction
“Test A” and “Test B” Performed Separately
Lumen Radius
[mm]
EEL Radius
[mm]
Plaque Thickness
[mm]
Endothelial SS
[dynes/cm2
]
r = 0.96 r = 0.95 r = 0.91 r = 0.88
Grid divided into 2,560-10,640 areas/artery (average 5,900/artery)
Each p < 0.0001
(Coskun, et al. JACC 2002, 39; 44A)
ArterialSegmentLength(mm)
In-Vivo Determination of the Natural History
of Restenosis and Atherosclerosis
• First pilot study of its kind in the world
• Complete intra-coronary flow profiling at index
catheterization and repeated at 6-month followup
• 10 patients enrolled:
– Followup catheterization completed in 8 patients
• one refused recath; one had clinical event prior to
recath
Pilot Study of Natural History of Progression of
Coronary Atherosclerosis and In-Stent Restenosis
Effect of Candesartan vs. Felodipine
ConsentandRandomize
Identification of
appropriate CAD
substrate:
-PTCA/stent
-obstruction < 50%
in adj artery, not
revascularized
Cath
# 1
Cath
# 2
Enter
BWH
System
Candesartan active
Felodipine placebo
Candesartan placebo
Felodipine active
Titration to BP < 140/90 mmHg
(Outpatient visits)
Time Line: Hours Time 0 Mo 1 Mo 2 Mo 3 Mo 6
Preliminary
identification
of hypertensive
patient
Inclusion Criteria:
• Hypertension
• CAD requiring stent
• Additional minor CAD
Pilot Study of Natural History of Progression of
Coronary Atherosclerosis and In-Stent Restenosis
Followup Status:
One patient refused repeat catheterization
One patient developed acute coronary syndrome
and required urgent cath and restenting
Serial Study Cohort: 8 patients
Native CAD Endpoints: 6 patients with serial studies
5 Felodipine and 1 patient Candesartan
Restenosis Endpoints: 6 patients with serial studies
3 Candesartan and 3 Felodipine
Pilot Study of Candesartan to Reduce Coronary
In-Stent Restenosis and
Progression of Atherosclerosis
Patient Population: 10 patients
9 men; 1 woman
Mean age: 60.8 years (range 37-83 years)
Concomitant medications: B-blockers, statins, and aspirin (all patients)
Mean fasting lipids: Total cholesterol: 156 mg/dl
LDL cholesterol: 95 mg/dl
HDL: 36 mg/dl
Triglycerides: 150 mg/dl
Blood Pressure:Baseline: 156/89 mmHg
Followup: 137/78 mmHg
Example of Coronary Atherosclerosis
Progression Over 6-Month Period
(Stone, et al. JACC 2002, 39: 217A)
Plaque Thickness [mm] Lumen Radius [mm] EEL Radius [mm] ESS [dynes/cm
2
]
Arterylength[mm]
Plaque Thickness
Increases in Areas
of Low ESS
Lumen Radius
Decreases in
Areas of Increased
Plaque Thickness
EEL Radius
Increases in
Distal Areas
ESS Increases
in Areas of
Plaque Increase
and Decreases
in Distal Areas
Example of Coronary Artery
“Outward Remodeling” Over 6-Month Period
Lumen Radius
[mm]
EEL Radius
[mm]
Plaque Thickness
[mm]
Endothelial SS
[dynes/cm2
]
Lumen radius
enlarges
Outer vessel radius
enlarges
Plaque thickness
does not change
ESS returns
to normal values
(Stone, et al. JACC 2002, 39: 217A)
ArterySegmentLength(mm)
Example of Instent Restenosis
Over 6-Month Period
Lumen Radius
[mm]
EEL Radius
[mm]
Plaque Thickness
[mm]
Endothelial SS
[dynes/cm2
]
Lumen radius
smaller within
stent,
larger outside
of stent
Outer vessel
radius
enlarges
Plaque thickens
within stent,
no change outside
stent
Endothelial
shear stress increases
within stent,
normalizes outside
stent
(Kinlay, et al. JACC 2002, 39: 5A)
ArterySegmentLength(mm)
Example of No Change in Stented Segment
Over 6-Month Period
Lumen Radius [mm] EEL Radius [mm] Plaque Thickness [mm] ESS [dynes/cm
2
]
ArterySegmentLength(mm)
(Kinlay, et al. JACC 2002, 39: 5A)
Conclusions
• This methodology allows for the first time in man the
systematic and serial in vivo investigation of the natural
history of CAD and consequent vascular responses.
• There are different and rapidly changing behaviors of
different areas within a coronary artery in response to
different ESS environments.
• The methodology can evaluate in detail the ESS that are
responsible for the development and progression of CAD,
as well as the remodeling that occurs in response to CAD.
• The technology may be invaluable to study the impact of
pharmacologic or device interventions on these natural
histories
References
• Asakura T, Karino T. Flow patterns and spatial distribution of atherosclerotic
lesions in human coronary arteries. Circ 1990; 66: 1045-66.
• Nosovitsky VA, et al. Effects of curvature and stenosis-like narrowing on wall
shear stress in a coronary artery model with phasic flow. Computer and
Biomed Res 1997; 9: 575-580.
• Malek A, et al. Hemodynamic shear stress and its role in atherosclerosis.
JAMA 1999; 282: 2035-42.
• Ward M, et al. Arterial remodeling. Mechanisms and clinical implications. Circ
2000; 102: 1186-91.
• Ilegbusi O, et al. Determination of blood flow and endothelial shear stress in
human coronary artery in vivo. J Invas Cardiol 1999; 11: 667-74.
• Feldman CL, et al. Determination of in vivo velocity and endothelial shear
stress patterns with phasic flow in human coronary arteries: A methodology to
predict progression of coronary atherosclerosis. Am Heart J 2002; 143: (in
press).
• Feldman CL, Stone PH. Intravascular hemodynamic factors responsible for
progression of coronary atherosclerosis and development of vulnerable
plaque. Curr Opin in Cardiol 2000; 15: 430-40.
References
• Coskun AU, et al. Reproducibility of 3-D lumen, plaque and outer vessel
reconstructions and of endothelial shear stress measurements in vivo
to determine progression of atherosclerosis. JACC 2002; 39: 44A.
• Stone PH, et al. Prediction of sites of progression of native coronary
disease in vivo based on identification of sites of low endothelial shear
stress. JACC 2002; 39: 217A.
• Kinlay S, et al. Endothelial shear stress identified in vivo within the stent
is related to in-stent restenosis and remodeling of stented coronary
arteries. JACC 2002; 39: 5A.
• Feldman CL, et al. In-vivo prediction of outward remodeling in native
portions of stented coronary arteries associated with sites of high
endothelial shear stress at the time of deployment. JACC 2002; 39:
247A.

More Related Content

What's hot

In stent retenosis treatment
In stent retenosis treatmentIn stent retenosis treatment
In stent retenosis treatmentNilesh Tawade
 
MT5007: The coronary stent revolution (A group project for the Management of ...
MT5007: The coronary stent revolution (A group project for the Management of ...MT5007: The coronary stent revolution (A group project for the Management of ...
MT5007: The coronary stent revolution (A group project for the Management of ...Stefan
 
Coronary Stent - Part A - Overview
Coronary Stent - Part A - OverviewCoronary Stent - Part A - Overview
Coronary Stent - Part A - OverviewAmir Kraitzer
 
Biovascular scaffolds - current status 2015
Biovascular scaffolds -  current status 2015Biovascular scaffolds -  current status 2015
Biovascular scaffolds - current status 2015Anshul Kumar Gupta
 
EFFECT OF NEGATIVE ANGLE CANNULATION DURING CARDIOPULMONARY BYPASS – A COMPUT...
EFFECT OF NEGATIVE ANGLE CANNULATION DURING CARDIOPULMONARY BYPASS – A COMPUT...EFFECT OF NEGATIVE ANGLE CANNULATION DURING CARDIOPULMONARY BYPASS – A COMPUT...
EFFECT OF NEGATIVE ANGLE CANNULATION DURING CARDIOPULMONARY BYPASS – A COMPUT...ijbesjournal
 
Bioabsorbable Scaffolds
Bioabsorbable ScaffoldsBioabsorbable Scaffolds
Bioabsorbable ScaffoldsAnkur Batra
 
Coronary Stent Design- Part B
Coronary Stent Design- Part BCoronary Stent Design- Part B
Coronary Stent Design- Part BAmir Kraitzer
 
AVN Head of Femur.pptx
AVN Head of Femur.pptxAVN Head of Femur.pptx
AVN Head of Femur.pptxKaush Upadhyay
 
Restenosis of DES: Classification and Management
Restenosis of DES: Classification and ManagementRestenosis of DES: Classification and Management
Restenosis of DES: Classification and Managementajay pratap singh
 
lecture august 2010
lecture august 2010lecture august 2010
lecture august 2010Imran Javed
 
Role of thrombolyitc therapy in ttt of ALI
Role of thrombolyitc therapy in ttt of ALIRole of thrombolyitc therapy in ttt of ALI
Role of thrombolyitc therapy in ttt of ALIAmr Mahmoud
 

What's hot (18)

Biovascular scaffolds
Biovascular scaffolds Biovascular scaffolds
Biovascular scaffolds
 
BVS IN STEMI
BVS IN STEMIBVS IN STEMI
BVS IN STEMI
 
In stent retenosis treatment
In stent retenosis treatmentIn stent retenosis treatment
In stent retenosis treatment
 
Basics of pci
Basics of pciBasics of pci
Basics of pci
 
In stent re stenosis
In stent re stenosisIn stent re stenosis
In stent re stenosis
 
MT5007: The coronary stent revolution (A group project for the Management of ...
MT5007: The coronary stent revolution (A group project for the Management of ...MT5007: The coronary stent revolution (A group project for the Management of ...
MT5007: The coronary stent revolution (A group project for the Management of ...
 
Endomyocardial biopsy
Endomyocardial biopsyEndomyocardial biopsy
Endomyocardial biopsy
 
Coronary Stent - Part A - Overview
Coronary Stent - Part A - OverviewCoronary Stent - Part A - Overview
Coronary Stent - Part A - Overview
 
Biovascular scaffolds - current status 2015
Biovascular scaffolds -  current status 2015Biovascular scaffolds -  current status 2015
Biovascular scaffolds - current status 2015
 
EFFECT OF NEGATIVE ANGLE CANNULATION DURING CARDIOPULMONARY BYPASS – A COMPUT...
EFFECT OF NEGATIVE ANGLE CANNULATION DURING CARDIOPULMONARY BYPASS – A COMPUT...EFFECT OF NEGATIVE ANGLE CANNULATION DURING CARDIOPULMONARY BYPASS – A COMPUT...
EFFECT OF NEGATIVE ANGLE CANNULATION DURING CARDIOPULMONARY BYPASS – A COMPUT...
 
Bioabsorbable Scaffolds
Bioabsorbable ScaffoldsBioabsorbable Scaffolds
Bioabsorbable Scaffolds
 
Coronary Stent Design- Part B
Coronary Stent Design- Part BCoronary Stent Design- Part B
Coronary Stent Design- Part B
 
AVN Head of Femur.pptx
AVN Head of Femur.pptxAVN Head of Femur.pptx
AVN Head of Femur.pptx
 
Endomyocardial Biopsy
Endomyocardial BiopsyEndomyocardial Biopsy
Endomyocardial Biopsy
 
Restenosis of DES: Classification and Management
Restenosis of DES: Classification and ManagementRestenosis of DES: Classification and Management
Restenosis of DES: Classification and Management
 
IN STENT RESTENOSIS
IN STENT RESTENOSISIN STENT RESTENOSIS
IN STENT RESTENOSIS
 
lecture august 2010
lecture august 2010lecture august 2010
lecture august 2010
 
Role of thrombolyitc therapy in ttt of ALI
Role of thrombolyitc therapy in ttt of ALIRole of thrombolyitc therapy in ttt of ALI
Role of thrombolyitc therapy in ttt of ALI
 

Viewers also liked

156 intravascular elastography
156 intravascular elastography156 intravascular elastography
156 intravascular elastographySHAPE Society
 
180 aortic thermography catheter
180 aortic thermography catheter180 aortic thermography catheter
180 aortic thermography catheterSHAPE Society
 
252 statin therapy influence on coronary calcification
252 statin therapy influence on coronary calcification252 statin therapy influence on coronary calcification
252 statin therapy influence on coronary calcificationSHAPE Society
 
059 can oct catheter see plaque macrophages
059 can oct catheter see plaque macrophages059 can oct catheter see plaque macrophages
059 can oct catheter see plaque macrophagesSHAPE Society
 
244 importance of vascular remodelling
244 importance of vascular remodelling244 importance of vascular remodelling
244 importance of vascular remodellingSHAPE Society
 
510 does lxr links lipid metabolism to inflammation, or ppar
510 does lxr links lipid metabolism to inflammation, or ppar510 does lxr links lipid metabolism to inflammation, or ppar
510 does lxr links lipid metabolism to inflammation, or pparSHAPE Society
 
114 evaluation of atherosclerotic plaque
114 evaluation of atherosclerotic plaque114 evaluation of atherosclerotic plaque
114 evaluation of atherosclerotic plaqueSHAPE Society
 
The Impact of carotid plaque screening on motivation for smoking cessation a...
The Impact of carotid plaque screening on motivation for smoking cessation  a...The Impact of carotid plaque screening on motivation for smoking cessation  a...
The Impact of carotid plaque screening on motivation for smoking cessation a...SHAPE Society
 
046 respiratory infection of apoe ko mice and plaque inflammation
046 respiratory infection of apoe ko mice and plaque inflammation046 respiratory infection of apoe ko mice and plaque inflammation
046 respiratory infection of apoe ko mice and plaque inflammationSHAPE Society
 
068 from vulnerable plaque to vulnerable patient
068 from vulnerable plaque to vulnerable patient068 from vulnerable plaque to vulnerable patient
068 from vulnerable plaque to vulnerable patientSHAPE Society
 
197 reducing atherosclerosis in mice
197 reducing atherosclerosis in mice197 reducing atherosclerosis in mice
197 reducing atherosclerosis in miceSHAPE Society
 
210 atherosclerosis, is it an autoimmune disease
210 atherosclerosis, is it an autoimmune disease210 atherosclerosis, is it an autoimmune disease
210 atherosclerosis, is it an autoimmune diseaseSHAPE Society
 
3rd vulnerable plaque rumberger 3 16-02 4
3rd vulnerable plaque rumberger 3 16-02 43rd vulnerable plaque rumberger 3 16-02 4
3rd vulnerable plaque rumberger 3 16-02 4SHAPE Society
 
260 mri system block diagram
260 mri system block diagram260 mri system block diagram
260 mri system block diagramSHAPE Society
 
145 intravascular elastography
145 intravascular elastography145 intravascular elastography
145 intravascular elastographySHAPE Society
 
132 gene expression in atherosclerotic plaques
132 gene expression in atherosclerotic plaques132 gene expression in atherosclerotic plaques
132 gene expression in atherosclerotic plaquesSHAPE Society
 
250 patients with very abnormal test results
250 patients with very abnormal test results250 patients with very abnormal test results
250 patients with very abnormal test resultsSHAPE Society
 
Acc 2002 mehran for print
Acc 2002  mehran for printAcc 2002  mehran for print
Acc 2002 mehran for printSHAPE Society
 

Viewers also liked (20)

156 intravascular elastography
156 intravascular elastography156 intravascular elastography
156 intravascular elastography
 
180 aortic thermography catheter
180 aortic thermography catheter180 aortic thermography catheter
180 aortic thermography catheter
 
252 statin therapy influence on coronary calcification
252 statin therapy influence on coronary calcification252 statin therapy influence on coronary calcification
252 statin therapy influence on coronary calcification
 
059 can oct catheter see plaque macrophages
059 can oct catheter see plaque macrophages059 can oct catheter see plaque macrophages
059 can oct catheter see plaque macrophages
 
244 importance of vascular remodelling
244 importance of vascular remodelling244 importance of vascular remodelling
244 importance of vascular remodelling
 
510 does lxr links lipid metabolism to inflammation, or ppar
510 does lxr links lipid metabolism to inflammation, or ppar510 does lxr links lipid metabolism to inflammation, or ppar
510 does lxr links lipid metabolism to inflammation, or ppar
 
114 evaluation of atherosclerotic plaque
114 evaluation of atherosclerotic plaque114 evaluation of atherosclerotic plaque
114 evaluation of atherosclerotic plaque
 
The Impact of carotid plaque screening on motivation for smoking cessation a...
The Impact of carotid plaque screening on motivation for smoking cessation  a...The Impact of carotid plaque screening on motivation for smoking cessation  a...
The Impact of carotid plaque screening on motivation for smoking cessation a...
 
046 respiratory infection of apoe ko mice and plaque inflammation
046 respiratory infection of apoe ko mice and plaque inflammation046 respiratory infection of apoe ko mice and plaque inflammation
046 respiratory infection of apoe ko mice and plaque inflammation
 
068 from vulnerable plaque to vulnerable patient
068 from vulnerable plaque to vulnerable patient068 from vulnerable plaque to vulnerable patient
068 from vulnerable plaque to vulnerable patient
 
198 pulse sequences
198 pulse sequences198 pulse sequences
198 pulse sequences
 
197 reducing atherosclerosis in mice
197 reducing atherosclerosis in mice197 reducing atherosclerosis in mice
197 reducing atherosclerosis in mice
 
210 atherosclerosis, is it an autoimmune disease
210 atherosclerosis, is it an autoimmune disease210 atherosclerosis, is it an autoimmune disease
210 atherosclerosis, is it an autoimmune disease
 
3rd vulnerable plaque rumberger 3 16-02 4
3rd vulnerable plaque rumberger 3 16-02 43rd vulnerable plaque rumberger 3 16-02 4
3rd vulnerable plaque rumberger 3 16-02 4
 
260 mri system block diagram
260 mri system block diagram260 mri system block diagram
260 mri system block diagram
 
145 intravascular elastography
145 intravascular elastography145 intravascular elastography
145 intravascular elastography
 
161 oct catheter
161 oct catheter161 oct catheter
161 oct catheter
 
132 gene expression in atherosclerotic plaques
132 gene expression in atherosclerotic plaques132 gene expression in atherosclerotic plaques
132 gene expression in atherosclerotic plaques
 
250 patients with very abnormal test results
250 patients with very abnormal test results250 patients with very abnormal test results
250 patients with very abnormal test results
 
Acc 2002 mehran for print
Acc 2002  mehran for printAcc 2002  mehran for print
Acc 2002 mehran for print
 

Similar to Acc vp-org 3-02 stone

Cerebrovascular atherosclerosis
Cerebrovascular atherosclerosis  Cerebrovascular atherosclerosis
Cerebrovascular atherosclerosis NeurologyKota
 
Spinal cord protection in aortic surgeries
Spinal cord protection in aortic surgeriesSpinal cord protection in aortic surgeries
Spinal cord protection in aortic surgeriesthanigai arasu
 
131 the evolution of coronary atherosclerosis
131 the evolution of coronary atherosclerosis131 the evolution of coronary atherosclerosis
131 the evolution of coronary atherosclerosisSHAPE Society
 
carotid stenosis and carotid artery stenting- un update
carotid stenosis and carotid artery stenting- un updatecarotid stenosis and carotid artery stenting- un update
carotid stenosis and carotid artery stenting- un updateDr Siva subramaniyan
 
1 enfermedad cv ateroesclerótica figura 1 (1)
1 enfermedad cv ateroesclerótica figura 1 (1)1 enfermedad cv ateroesclerótica figura 1 (1)
1 enfermedad cv ateroesclerótica figura 1 (1)sagita28
 
Intracranial atherosclerotic disease
Intracranial atherosclerotic diseaseIntracranial atherosclerotic disease
Intracranial atherosclerotic diseaseNeurologyKota
 
Statistical analysis for measuring the effects of stenotic shapes and spiral ...
Statistical analysis for measuring the effects of stenotic shapes and spiral ...Statistical analysis for measuring the effects of stenotic shapes and spiral ...
Statistical analysis for measuring the effects of stenotic shapes and spiral ...Iwate University
 
Coronary Ostial stenting techniques:Current status
Coronary Ostial stenting techniques:Current statusCoronary Ostial stenting techniques:Current status
Coronary Ostial stenting techniques:Current statusPawan Ola
 
Imaging in ischemic stroke
Imaging in ischemic strokeImaging in ischemic stroke
Imaging in ischemic strokesks200166
 
Imaging in ischemic stroke18 11-15 final
Imaging in ischemic stroke18 11-15 finalImaging in ischemic stroke18 11-15 final
Imaging in ischemic stroke18 11-15 finalNeurologyKota
 
MODELLING STENOSIS DEVELOPMENT IN THE CAROTID ARTERY AT THE EARLY STAGES OF S...
MODELLING STENOSIS DEVELOPMENT IN THE CAROTID ARTERY AT THE EARLY STAGES OF S...MODELLING STENOSIS DEVELOPMENT IN THE CAROTID ARTERY AT THE EARLY STAGES OF S...
MODELLING STENOSIS DEVELOPMENT IN THE CAROTID ARTERY AT THE EARLY STAGES OF S...Katerina Stamou
 
Journal club april 2015
Journal club april 2015Journal club april 2015
Journal club april 2015Kunal Mahajan
 
Coronary ct angiography
Coronary ct angiographyCoronary ct angiography
Coronary ct angiographySGPGI, lucknow
 
Cardiac CT Angiography to detect Myocardial Bridging
Cardiac CT Angiography to detect Myocardial Bridging Cardiac CT Angiography to detect Myocardial Bridging
Cardiac CT Angiography to detect Myocardial Bridging Han Naung Tun
 
Infective endocarditis Echocardiography
Infective endocarditis EchocardiographyInfective endocarditis Echocardiography
Infective endocarditis EchocardiographySruthi Meenaxshi
 

Similar to Acc vp-org 3-02 stone (20)

Cerebrovascular atherosclerosis
Cerebrovascular atherosclerosis  Cerebrovascular atherosclerosis
Cerebrovascular atherosclerosis
 
Spinal cord protection in aortic surgeries
Spinal cord protection in aortic surgeriesSpinal cord protection in aortic surgeries
Spinal cord protection in aortic surgeries
 
Carotid angioplasty
Carotid angioplastyCarotid angioplasty
Carotid angioplasty
 
carotid angioplasty
carotid angioplastycarotid angioplasty
carotid angioplasty
 
131 the evolution of coronary atherosclerosis
131 the evolution of coronary atherosclerosis131 the evolution of coronary atherosclerosis
131 the evolution of coronary atherosclerosis
 
Dr stone
Dr stoneDr stone
Dr stone
 
131 the evolution of coronary atherosclerosis
131 the evolution of coronary atherosclerosis131 the evolution of coronary atherosclerosis
131 the evolution of coronary atherosclerosis
 
carotid stenosis and carotid artery stenting- un update
carotid stenosis and carotid artery stenting- un updatecarotid stenosis and carotid artery stenting- un update
carotid stenosis and carotid artery stenting- un update
 
1 enfermedad cv ateroesclerótica figura 1 (1)
1 enfermedad cv ateroesclerótica figura 1 (1)1 enfermedad cv ateroesclerótica figura 1 (1)
1 enfermedad cv ateroesclerótica figura 1 (1)
 
Intracranial atherosclerotic disease
Intracranial atherosclerotic diseaseIntracranial atherosclerotic disease
Intracranial atherosclerotic disease
 
Statistical analysis for measuring the effects of stenotic shapes and spiral ...
Statistical analysis for measuring the effects of stenotic shapes and spiral ...Statistical analysis for measuring the effects of stenotic shapes and spiral ...
Statistical analysis for measuring the effects of stenotic shapes and spiral ...
 
Coronary Ostial stenting techniques:Current status
Coronary Ostial stenting techniques:Current statusCoronary Ostial stenting techniques:Current status
Coronary Ostial stenting techniques:Current status
 
Imaging in ischemic stroke
Imaging in ischemic strokeImaging in ischemic stroke
Imaging in ischemic stroke
 
Imaging in ischemic stroke18 11-15 final
Imaging in ischemic stroke18 11-15 finalImaging in ischemic stroke18 11-15 final
Imaging in ischemic stroke18 11-15 final
 
MODELLING STENOSIS DEVELOPMENT IN THE CAROTID ARTERY AT THE EARLY STAGES OF S...
MODELLING STENOSIS DEVELOPMENT IN THE CAROTID ARTERY AT THE EARLY STAGES OF S...MODELLING STENOSIS DEVELOPMENT IN THE CAROTID ARTERY AT THE EARLY STAGES OF S...
MODELLING STENOSIS DEVELOPMENT IN THE CAROTID ARTERY AT THE EARLY STAGES OF S...
 
Journal club april 2015
Journal club april 2015Journal club april 2015
Journal club april 2015
 
Coronary ct angiography
Coronary ct angiographyCoronary ct angiography
Coronary ct angiography
 
Cardiac CT Angiography to detect Myocardial Bridging
Cardiac CT Angiography to detect Myocardial Bridging Cardiac CT Angiography to detect Myocardial Bridging
Cardiac CT Angiography to detect Myocardial Bridging
 
Ec ic bypass
Ec ic bypassEc ic bypass
Ec ic bypass
 
Infective endocarditis Echocardiography
Infective endocarditis EchocardiographyInfective endocarditis Echocardiography
Infective endocarditis Echocardiography
 

More from SHAPE Society

101205 shape aha 2005 f
101205 shape aha 2005 f101205 shape aha 2005 f
101205 shape aha 2005 fSHAPE Society
 
Acc presentation macrophage (1)
Acc presentation macrophage (1)Acc presentation macrophage (1)
Acc presentation macrophage (1)SHAPE Society
 
Acc presentation (1)
Acc presentation (1)Acc presentation (1)
Acc presentation (1)SHAPE Society
 
Acc presentation lipid coated(2)
Acc presentation lipid coated(2)Acc presentation lipid coated(2)
Acc presentation lipid coated(2)SHAPE Society
 
Acc 2002 microarray mehran for print
Acc 2002 microarray mehran for printAcc 2002 microarray mehran for print
Acc 2002 microarray mehran for printSHAPE Society
 
Acc2002 thermography
Acc2002 thermographyAcc2002 thermography
Acc2002 thermographySHAPE Society
 
#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st centurySHAPE Society
 
A20 is an atherosclerosis
A20 is an atherosclerosisA20 is an atherosclerosis
A20 is an atherosclerosisSHAPE Society
 
259 crp as a risk factor
259 crp as a risk factor259 crp as a risk factor
259 crp as a risk factorSHAPE Society
 
511 first steps towards understanding
511 first steps towards understanding511 first steps towards understanding
511 first steps towards understandingSHAPE Society
 

More from SHAPE Society (20)

Barth imt
Barth imtBarth imt
Barth imt
 
Braunwald
BraunwaldBraunwald
Braunwald
 
101205 shape aha 2005 f
101205 shape aha 2005 f101205 shape aha 2005 f
101205 shape aha 2005 f
 
Acc v porg becker
Acc v porg beckerAcc v porg becker
Acc v porg becker
 
Acc 2005-1, v pl-vp
Acc 2005-1, v pl-vpAcc 2005-1, v pl-vp
Acc 2005-1, v pl-vp
 
Acc presentation macrophage (1)
Acc presentation macrophage (1)Acc presentation macrophage (1)
Acc presentation macrophage (1)
 
Acc v porg
Acc v porgAcc v porg
Acc v porg
 
Acc presentation (1)
Acc presentation (1)Acc presentation (1)
Acc presentation (1)
 
Ac cculprit
Ac cculpritAc cculprit
Ac cculprit
 
Acc presentation lipid coated(2)
Acc presentation lipid coated(2)Acc presentation lipid coated(2)
Acc presentation lipid coated(2)
 
Acc 2002 microarray mehran for print
Acc 2002 microarray mehran for printAcc 2002 microarray mehran for print
Acc 2002 microarray mehran for print
 
Acc booth inventory
Acc booth inventoryAcc booth inventory
Acc booth inventory
 
Acc 04 vuln pt
Acc 04 vuln ptAcc 04 vuln pt
Acc 04 vuln pt
 
Acc2002 thermography
Acc2002 thermographyAcc2002 thermography
Acc2002 thermography
 
A20 gene
A20 geneA20 gene
A20 gene
 
#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century#1 killer of human beings in the 21st century
#1 killer of human beings in the 21st century
 
A20 is an atherosclerosis
A20 is an atherosclerosisA20 is an atherosclerosis
A20 is an atherosclerosis
 
103100
103100103100
103100
 
259 crp as a risk factor
259 crp as a risk factor259 crp as a risk factor
259 crp as a risk factor
 
511 first steps towards understanding
511 first steps towards understanding511 first steps towards understanding
511 first steps towards understanding
 

Recently uploaded

CANCER SeminarCancer Overview Type of Cancer.pptx
CANCER SeminarCancer Overview  Type of Cancer.pptxCANCER SeminarCancer Overview  Type of Cancer.pptx
CANCER SeminarCancer Overview Type of Cancer.pptxMrStavanUdayKadam
 
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomNeurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomSudhir Kumar
 
Ayurveda research in Hypothyroidism, P
Ayurveda  research  in Hypothyroidism, PAyurveda  research  in Hypothyroidism, P
Ayurveda research in Hypothyroidism, PDr.Shalu Jain
 
airway management recorded for S2.pptx
airway management  recorded  for S2.pptxairway management  recorded  for S2.pptx
airway management recorded for S2.pptxnakera38
 
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKLaryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKQuick MedTalk
 
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptINTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptKavitha Krishnan
 
SGK VIÊM KHỚP DẠNG THẤP YHN .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN              .pdfSGK VIÊM KHỚP DẠNG THẤP YHN              .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN .pdfHongBiThi1
 
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptxCholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptxRajendra Dev Bhatt
 
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...DUY NGUYEN PHUC
 
Ten lessons learnt as anesthetist.pptx
Ten  lessons  learnt as anesthetist.pptxTen  lessons  learnt as anesthetist.pptx
Ten lessons learnt as anesthetist.pptxtusharchokshi1
 
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdfEMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdfMayuriGamit2
 
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...Genesis Institute of Pharmacy, Radhanagari.
 
Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Ahmad Thanin
 
Brief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptxBrief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptxTina Purnat
 
Reproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptxReproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptxVeereshDemashetti
 
(IDE)and(IVD),QMS,21 CFR part820 , 801)
(IDE)and(IVD),QMS,21 CFR part820  , 801)(IDE)and(IVD),QMS,21 CFR part820  , 801)
(IDE)and(IVD),QMS,21 CFR part820 , 801)chahattyagi200
 
The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...JakeMatthews12
 
TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHUTARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHUKanhu Charan
 
Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)pranavguleria2
 
Ortho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limitedOrtho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limitedSBL DIGITAL
 

Recently uploaded (20)

CANCER SeminarCancer Overview Type of Cancer.pptx
CANCER SeminarCancer Overview  Type of Cancer.pptxCANCER SeminarCancer Overview  Type of Cancer.pptx
CANCER SeminarCancer Overview Type of Cancer.pptx
 
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomNeurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
 
Ayurveda research in Hypothyroidism, P
Ayurveda  research  in Hypothyroidism, PAyurveda  research  in Hypothyroidism, P
Ayurveda research in Hypothyroidism, P
 
airway management recorded for S2.pptx
airway management  recorded  for S2.pptxairway management  recorded  for S2.pptx
airway management recorded for S2.pptx
 
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALKLaryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
Laryngeal papillomatosis .pdf ENT BY QUICKMEDTALK
 
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptINTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
 
SGK VIÊM KHỚP DẠNG THẤP YHN .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN              .pdfSGK VIÊM KHỚP DẠNG THẤP YHN              .pdf
SGK VIÊM KHỚP DẠNG THẤP YHN .pdf
 
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptxCholesterol Biosynthesis  and catabolism for MBBS, Lab. MEd. BDS.pptx
Cholesterol Biosynthesis and catabolism for MBBS, Lab. MEd. BDS.pptx
 
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...Routine Medicine Laboratory Testing  _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
Routine Medicine Laboratory Testing _ CÁC XÉT NGHIỆM THƯỜNG QUY ÁP DỤNG TRON...
 
Ten lessons learnt as anesthetist.pptx
Ten  lessons  learnt as anesthetist.pptxTen  lessons  learnt as anesthetist.pptx
Ten lessons learnt as anesthetist.pptx
 
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdfEMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
 
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
 
Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)
 
Brief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptxBrief introduction to information ecosystem x public health.pptx
Brief introduction to information ecosystem x public health.pptx
 
Reproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptxReproductive and Child Health Services ppt.pptx
Reproductive and Child Health Services ppt.pptx
 
(IDE)and(IVD),QMS,21 CFR part820 , 801)
(IDE)and(IVD),QMS,21 CFR part820  , 801)(IDE)and(IVD),QMS,21 CFR part820  , 801)
(IDE)and(IVD),QMS,21 CFR part820 , 801)
 
The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...
 
TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHUTARGET DELINEATION IN CERVIX CANCER BY DR KANHU
TARGET DELINEATION IN CERVIX CANCER BY DR KANHU
 
Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)Histology of lymph node(lymph node histology)
Histology of lymph node(lymph node histology)
 
Ortho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limitedOrtho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limited
 

Acc vp-org 3-02 stone

  • 1. Coronary Endothelial Shear Stress Profiling In-Vivo to Predict Progression of Atherosclerosis and In-Stent Restenosis in Man Peter H. Stone, M.D. Ahmet U. Coskun, Ph.D. Scott Kinlay, M.D., Ph.D., Maureen E. Clark, M.S. Milan Sonka, Ph.D. Andreas Wahle, Ph.D., Olusegun J. Ilegbusi, Ph.D. Yerem Yeghiazarians, M.D. Jeffrey J. Popma, M.D. Richard E. Kuntz, M.D., M.S. Charles L. Feldman, Sc.D. Cardiovascular Division, Brigham & Women’s Hospital, Harvard Medical School; Department of Mechanical, Industrial and Manufacturing Engineering, Northeastern University; Department of Electrical and Computer Engineering, University of Iowa
  • 2. Abstract - 1 The focal and eccentric nature of CAD must be related to local hemodynamic factors. The endothelium is uniquely capable of controlling local arterial responses by transduction of hemodynamic shear stress. Low or reversed shear stress (< ~10 dynes/cm2 ) leads to plaque development and progression. Physiologic shear stress (~10 - 30 dynes/cm2 ) is vasculoprotective, maintaining normal vascular morphology. Increased shear stress (> ~ 30 dynes/cm2 ) promotes outward remodeling and platelet aggregation. Characterization of shear stress along the coronary artery may allow for prediction of progression of atherosclerosis and vascular remodeling.
  • 3. Abstract - 2 Current methodologies cannot provide adequate information concerning the micro-environment of the coronary arteries. We developed a unique system using intravascular ultrasound (IVUS), biplane coronary angiography, and measurements of coronary blood flow, to present the artery in accurate 3-D space, and to produce detailed characteristics of intravascular flow, ESS, and arterial wall and plaque morphology. We observed that over 6 mo followup, areas of low ESS demonstrated plaque progression, areas of physiologic ESS remained quiescent, and areas of increased ESS developed outward remodeling. The technology may be invaluable to study the impact of pharmacologic or device interventions on the natural history of coronary disease.
  • 4. Fundamental Nature of the Problem • Although all portions of the coronary arterial tree are exposed to the same systemic risk factors, atherosclerosis is focal and eccentric • Each coronary artery has many different obstructions in different “stages” of evolution: – There is not a “wave-front” of vulnerability and consequent rupture.
  • 5. Varying Degrees of CAD Lesion Severity in a Single Coronary Artery
  • 6. Fundamental Nature of the Problem • Coronary atherosclerotic obstructions behave differently based on the degree of luminal obstruction and morphology: – Lesions > 50-75% obstruction Angina Pectoris – Lesions < 50% obstruction Rupture,superimposed thrombus, MI, death These small, potentially lethal lesions are,These small, potentially lethal lesions are, therefore, “clinically silent” until they rupture.therefore, “clinically silent” until they rupture. • It would be of enormous value to identify minorIt would be of enormous value to identify minor obstructions which were progressing and/orobstructions which were progressing and/or evolving towards “vulnerability” since they could beevolving towards “vulnerability” since they could be treated before rupture occurred, thereby avertingtreated before rupture occurred, thereby averting an acute coronary syndrome.an acute coronary syndrome.
  • 7. Nature of Progression of Atherosclerosis • The only truly local phenomena which could lead to varying local vascular responses are endothelial shear stresses (ESS) • Local ESS variations are critical: – Low ESS and disturbed flow (< 6-10 dynes/cm2 ) • Causes atheroma; pro-thrombotic, pro-migration, pro-apoptosis – Physiologic shear stress and laminar flow (10-30 dynes/cm2 ) • Vasculoprotective, anti-thrombotic, anti-migration, pro-survival – High shear stress and turbulent flow (> 30 dynes/cm2 ) • Promotes platelet activation, thrombus formation, and probably plaque rupture • Until now,Until now, in vivoin vivo determination of intracoronary flow velocitydetermination of intracoronary flow velocity and endothelial shear stress has not been possible.and endothelial shear stress has not been possible.
  • 8. The Detrimental Effect of Low Shear Stress on Endothelial Structure and Function Low shear stresses and disturbed local flow (< ~ 6 dynes/cm2 ) are atherogenic: (Malek, et al. JAMA 1999; 282:2035) • Cell proliferation, migration • Expression of vascular adhesion molecules, cytokines, mitogens • Monocyte recruitment and activation • Procoagulant and prothrombotic state • Local oxidation Promotes:
  • 9. The Effect of Physiologic Shear Stress on Endothelial Structure and Function Physiologic shear stress (~15-50 dynes/cm2 ) is vasculoprotective: (Malek, et al. JAMA 1999; 282:2035) • Enhances endothelial quiescence - decreases proliferation • Enhances vasodilation • Enhances anti-oxidant status • Enhances anti-coagulant and anti-thrombotic status
  • 10. Overview of Intracoronary Flow Profiling System Patient • Coronary angiography • Intracoronary ultrasound • Coronary flow (TIMI Frame Count) Acquire image data 3D reconstruction of lumen, EEL, Plaque Generation of grid for Computational Fluid Dynamics Numerical computation Determination of local velocity vectors and shear stress Application of vascular data to patient care Prediction of restenosis Prediction of CAD progression
  • 11. Intracoronary Flow Profiling Methods • The intracoronary ultrasound (ICUS) “core” is positioned in the relevant section of the artery and a biplane angiogram is recorded using dilute contrast. • ICUS is performed with controlled pull-back at 0.5 mm/sec with biplane angiography. ECG is simultaneously recorded for “gating.” • A dynamic programming technique extracts the lumen and EEL outline from the ICUS at end-diastolic frames and re-aligns them. • The ICUS frames are realigned in 3-D space perpendicular to the ICUS core image. • The reconstructed lumen is divided into computational control volumes comprising 0.3 mm thick slices along the segment, 40 equal intervals around the circumference, and 16 intervals in the radial direction. • Dividing the blood into small “cubes” on the grid, the Navier-Stokes equations of fluid flow are solved numerically using an iterative procedure (Computational Fluid Dynamics). • Shear stress at the wall is obtained by multiplying viscosity by the velocity gradient at the wall.
  • 12. Selected ICUS frames Total number of frames ≈ 100-200/arterial segment
  • 13. Measurements of Lumen, Outer Vessel Wall, and Plaque by IVUS (DeFranco. AJC 2001; 88 [Suppl]: 7M) • Lumen • Outer Vessel Wall = Area within EEM • Plaque = Intimal-Medial Thickness
  • 16. Creation of Computational Mesh 640 Cells per cross-section 3mm
  • 17. Representative Example of 3-D Reconstruction of Coronary Artery RAO projection LAO projection
  • 18. Example of 3-D Reconstruction of Coronary Artery Solid line passing through the centroid of the lumen defines a pathline Perpendicular distance between pathline and lumen border defines local lumen radius, perpendicular distance between EEL border and pathline defines the local EEL radius Difference between local EEL and lumen radii defines local plaque thickness
  • 19. Original angiogram of a portion of an artery studied Composite reconstruction of portion of the arterial segment, consisting of outer arterial wall, plaque, and lumen: Isolated view of reconstructed outer arterial wall: Isolated view of reconstructed lumen: Isolated view of reconstructed atherosclerotic plaque: Example of 3-D Reconstruction of Arterial Segment
  • 20. Velocity Field Presented As A Longitudinal Section
  • 21. Coronary Endothelial Shear Stress w y u WSS ∂ ∂ µ= dynes/cm2 [Artery is displayed as if it were cut and opened longitudinally, as a pathologist would view it.]
  • 22. Reproducibility Studies of Intra-coronary Flow Profiling Measurements Cardiac catheterization and coronary angiography – Patients studied completely with ICUS pullback and biplane angiography (“Test A”) – All catheters removed, and after a few minutes, entire procedure repeated (“Test B”): • catheters reinserted • angle, skew, table height reproduced to mimic the initial procedure – All calculations performed to measure lumen, outer vessel, plaque morphology, and endothelial shear stress
  • 23. Reproducibility of 3-D Coronary Artery Reconstruction “Test A” and “Test B” Performed Separately Lumen Radius [mm] EEL Radius [mm] Plaque Thickness [mm] Endothelial SS [dynes/cm2 ] r = 0.96 r = 0.95 r = 0.91 r = 0.88 Grid divided into 2,560-10,640 areas/artery (average 5,900/artery) Each p < 0.0001 (Coskun, et al. JACC 2002, 39; 44A) ArterialSegmentLength(mm)
  • 24. In-Vivo Determination of the Natural History of Restenosis and Atherosclerosis • First pilot study of its kind in the world • Complete intra-coronary flow profiling at index catheterization and repeated at 6-month followup • 10 patients enrolled: – Followup catheterization completed in 8 patients • one refused recath; one had clinical event prior to recath
  • 25. Pilot Study of Natural History of Progression of Coronary Atherosclerosis and In-Stent Restenosis Effect of Candesartan vs. Felodipine ConsentandRandomize Identification of appropriate CAD substrate: -PTCA/stent -obstruction < 50% in adj artery, not revascularized Cath # 1 Cath # 2 Enter BWH System Candesartan active Felodipine placebo Candesartan placebo Felodipine active Titration to BP < 140/90 mmHg (Outpatient visits) Time Line: Hours Time 0 Mo 1 Mo 2 Mo 3 Mo 6 Preliminary identification of hypertensive patient Inclusion Criteria: • Hypertension • CAD requiring stent • Additional minor CAD
  • 26. Pilot Study of Natural History of Progression of Coronary Atherosclerosis and In-Stent Restenosis Followup Status: One patient refused repeat catheterization One patient developed acute coronary syndrome and required urgent cath and restenting Serial Study Cohort: 8 patients Native CAD Endpoints: 6 patients with serial studies 5 Felodipine and 1 patient Candesartan Restenosis Endpoints: 6 patients with serial studies 3 Candesartan and 3 Felodipine
  • 27. Pilot Study of Candesartan to Reduce Coronary In-Stent Restenosis and Progression of Atherosclerosis Patient Population: 10 patients 9 men; 1 woman Mean age: 60.8 years (range 37-83 years) Concomitant medications: B-blockers, statins, and aspirin (all patients) Mean fasting lipids: Total cholesterol: 156 mg/dl LDL cholesterol: 95 mg/dl HDL: 36 mg/dl Triglycerides: 150 mg/dl Blood Pressure:Baseline: 156/89 mmHg Followup: 137/78 mmHg
  • 28. Example of Coronary Atherosclerosis Progression Over 6-Month Period (Stone, et al. JACC 2002, 39: 217A) Plaque Thickness [mm] Lumen Radius [mm] EEL Radius [mm] ESS [dynes/cm 2 ] Arterylength[mm] Plaque Thickness Increases in Areas of Low ESS Lumen Radius Decreases in Areas of Increased Plaque Thickness EEL Radius Increases in Distal Areas ESS Increases in Areas of Plaque Increase and Decreases in Distal Areas
  • 29. Example of Coronary Artery “Outward Remodeling” Over 6-Month Period Lumen Radius [mm] EEL Radius [mm] Plaque Thickness [mm] Endothelial SS [dynes/cm2 ] Lumen radius enlarges Outer vessel radius enlarges Plaque thickness does not change ESS returns to normal values (Stone, et al. JACC 2002, 39: 217A) ArterySegmentLength(mm)
  • 30. Example of Instent Restenosis Over 6-Month Period Lumen Radius [mm] EEL Radius [mm] Plaque Thickness [mm] Endothelial SS [dynes/cm2 ] Lumen radius smaller within stent, larger outside of stent Outer vessel radius enlarges Plaque thickens within stent, no change outside stent Endothelial shear stress increases within stent, normalizes outside stent (Kinlay, et al. JACC 2002, 39: 5A) ArterySegmentLength(mm)
  • 31. Example of No Change in Stented Segment Over 6-Month Period Lumen Radius [mm] EEL Radius [mm] Plaque Thickness [mm] ESS [dynes/cm 2 ] ArterySegmentLength(mm) (Kinlay, et al. JACC 2002, 39: 5A)
  • 32. Conclusions • This methodology allows for the first time in man the systematic and serial in vivo investigation of the natural history of CAD and consequent vascular responses. • There are different and rapidly changing behaviors of different areas within a coronary artery in response to different ESS environments. • The methodology can evaluate in detail the ESS that are responsible for the development and progression of CAD, as well as the remodeling that occurs in response to CAD. • The technology may be invaluable to study the impact of pharmacologic or device interventions on these natural histories
  • 33. References • Asakura T, Karino T. Flow patterns and spatial distribution of atherosclerotic lesions in human coronary arteries. Circ 1990; 66: 1045-66. • Nosovitsky VA, et al. Effects of curvature and stenosis-like narrowing on wall shear stress in a coronary artery model with phasic flow. Computer and Biomed Res 1997; 9: 575-580. • Malek A, et al. Hemodynamic shear stress and its role in atherosclerosis. JAMA 1999; 282: 2035-42. • Ward M, et al. Arterial remodeling. Mechanisms and clinical implications. Circ 2000; 102: 1186-91. • Ilegbusi O, et al. Determination of blood flow and endothelial shear stress in human coronary artery in vivo. J Invas Cardiol 1999; 11: 667-74. • Feldman CL, et al. Determination of in vivo velocity and endothelial shear stress patterns with phasic flow in human coronary arteries: A methodology to predict progression of coronary atherosclerosis. Am Heart J 2002; 143: (in press). • Feldman CL, Stone PH. Intravascular hemodynamic factors responsible for progression of coronary atherosclerosis and development of vulnerable plaque. Curr Opin in Cardiol 2000; 15: 430-40.
  • 34. References • Coskun AU, et al. Reproducibility of 3-D lumen, plaque and outer vessel reconstructions and of endothelial shear stress measurements in vivo to determine progression of atherosclerosis. JACC 2002; 39: 44A. • Stone PH, et al. Prediction of sites of progression of native coronary disease in vivo based on identification of sites of low endothelial shear stress. JACC 2002; 39: 217A. • Kinlay S, et al. Endothelial shear stress identified in vivo within the stent is related to in-stent restenosis and remodeling of stented coronary arteries. JACC 2002; 39: 5A. • Feldman CL, et al. In-vivo prediction of outward remodeling in native portions of stented coronary arteries associated with sites of high endothelial shear stress at the time of deployment. JACC 2002; 39: 247A.